Healthcare professionals should discuss the purpose, duration, frequency and location of follow-up with each man with localised prostate cancer8 , and if he wishes, his partner or carers. Men with prostate cancer should be clearly advised about potential longer term adverse effects and when and how to report them. Men with prostate cancer who have chosen a watchful waiting regimen with no curative intent should normally be followed up in primary care in accordance with protocols agreed by the local urological cancer MDT and the relevant primary care organisation(s). Their PSA should be measured at least once a.
